Okacet L Plus Suspension
By Okacet L Plus
Rx
60ml Suspension in a Bottle

Composition
Levocetirizine(NA) + Phenylephrine(NA) + Paracetamol(NA)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
August, 2025

liver
When using Okacet L Plus Suspension, caution is advised for patients with liver disease. It may be necessary to adjust the dosage of the suspension in such cases. It is important to consult your doctor before using this medication if you have liver issues. However, it is not recommended to use Okacet L Plus Suspension in patients with severe liver disease or active liver disease. If you have concerns about your liver health, seek guidance from your healthcare provider before starting this medication.

kidney
Okacet L Plus Suspension should be used carefully if you have kidney disease. Your doctor may need to adjust the dose. Avoid using if you have severe kidney disease. Always consult your doctor before using Okacet L Plus Suspension.

alcohol
It is not safe to drink alcohol while taking Okacet L Plus Suspension, as this can be harmful. It is important to avoid alcohol when using this medication. If you are pregnant, always consult your doctor before taking any medications.

driving
Okacet L Plus Suspension may reduce alertness, affect vision, or cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Okacet L Plus Suspension may not be safe to use during pregnancy. Animal studies suggest potential harm to the developing baby. Consult your doctor for guidance on risks and benefits before using.

breastfeeding
Okacet L Plus Suspension is considered safe for breastfeeding. Limited human data indicates minimal risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹20
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024